| SCHEDULE OF GEOGRAPHICAL INFORMATION IN NON-CURRENT ASSETS |
Non-current
assets (excluding investment in associate) information based on the location of assets are as follows:
SCHEDULE OF GEOGRAPHICAL INFORMATION IN NON-CURRENT ASSETS
| | |
2024 | | |
2025 | |
| | |
2024 | | |
2025 | |
| | |
S$ | | |
S$ | |
| | |
| | |
| |
| Malaysia | |
| 2,764,642 | | |
| 3,272,486 | |
| Singapore | |
| 1,081,454 | | |
| 1,049,492 | |
| Total | |
| 3,846,096 | | |
| 4,321,978 | |
|
| SCHEDULE OF BUSINESS SEGMENT |
SCHEDULE OF BUSINESS SEGMENT
| | |
2024 | | |
2024 | | |
2025 | | |
2025 | | |
2024 | | |
2025 | |
| | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | | |
S$ | |
| | |
Immune cell | | |
CBU service & | | |
Immune cell | | |
CBU service & | | |
| | |
| |
| | |
therapy | | |
related therapy | | |
therapy | | |
related therapy | | |
Consolidated | | |
Consolidated | |
| Revenue | |
| - | | |
| 69,501 | | |
| - | | |
| 324,387 | | |
| 69,501 | | |
| 324,387 | |
| Private blood banking expenses | |
| - | | |
| (17,121 | ) | |
| - | | |
| (67,992 | ) | |
| (17,121 | ) | |
| (67,992 | ) |
| Operating results | |
| (2,288,907 | ) | |
| (69,309 | ) | |
| (3,705,474 | ) | |
| (158,832 | ) | |
| (2,358,216 | ) | |
| (3,864,306 | ) |
| Non-current assets | |
| 3,255,888 | | |
| 811,158 | | |
| 3,095,610 | | |
| 1,226,368 | | |
| 4,067,046 | | |
| 4,321,978 | |
| Total assets | |
| 9,059,086 | | |
| 1,008,663 | | |
| 5,930,746 | | |
| 2,054,207 | | |
| 10,067,749 | | |
| 7,984,953 | |
| Non-current liabilities | |
| 394,311 | | |
| 23,027 | | |
| 369,535 | | |
| 52,582 | | |
| 417,338 | | |
| 422,117 | |
| Total liabilities | |
| 871,435 | | |
| 152,525 | | |
| 457,066 | | |
| 674,220 | | |
| 1,023,960 | | |
| 1,131,286 | |
| Equity | |
| 8,246,154 | | |
| 797,635 | | |
| 7,125,613 | | |
| (271,946 | ) | |
| 9,043,789 | | |
| 6,853,667 | |
|